Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
INPHI On Other Exchanges
New York
EN Amsterdam
EN Amsterdam
All times are local (Market data is delayed by at least 15 minutes).

philips electronics nv (INPHI) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

philips electronics nv (INPHI) Related Bloomberg News

View More Bloomberg News

philips electronics nv (INPHI) Details

Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, including radiation oncology and portfolio management; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products. The company also offers enterprise patient monitoring solutions for clinical information at the patient’s bedside; patient analytics, patient monitoring, and clinical decision support systems; mother and child care products; therapeutic care products; imaging informatics for radiology and cardiology; picture archiving and communication systems and integrated electronic medical record systems; professional services; clinical support and performance, education, value-added services, installation, and remote proactive monitoring services; and care coordination, home monitoring, and care solutions. In addition, it provides mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Further, the company is involved in the development, manufacture, and application of various lighting products and services, including light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; functional, decorative, lifestyle, and scene-setting luminaires; and controls and luminaires for city beautification, road and sports lighting, office lighting, shop/hospitality lighting, and industry lighting. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is based in Amsterdam, the Netherlands.

93,706 Employees
Last Reported Date: 04/28/15
Founded in 1891

philips electronics nv (INPHI) Top Compensated Officers

Chairman of the Board of Management, Chief Ex...
Total Annual Compensation: €1.5M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €869.1K
Executive Vice-President, Member of Board of ...
Total Annual Compensation: €901.9K
Compensation as of Fiscal Year 2014.

philips electronics nv (INPHI) Key Developments

Koninklijke Philips N.V Announces Earnings Results for the Second Quarter of 2015; Provides Earnings Guidance for the Year 2015 and 2016

Koninklijke Philips N.V announced earnings results for the second quarter of 2015. For the quarter, adjusted earnings before interest, taxes and amortization rose 27% to EUR 501 million ($550 million). Sales jumped 20% to EUR 5.97 billion from EUR 4.97 billion in the prior year. The net profit attributable to shareholders was EUR 272 million ($301 million). The operating profit was EUR 415 million. The company had an outflow of free cash of EUR 30 million. Comparable sales increased by 3% to EUR 6 billion compared to the last year. The company expects to turn in modest sales growth this year and improve its operational performance in both 2015 and 2016.

Philips Mulls Sale Of Lighting Division

Koninklijke Philips N.V (ENXTAM:PHIA) may sell unit. The company is looking to divest its lighting division through either a sale or a stock market flotation.

Profound Medical Signs Joint Development Agreement with Royal Philips on Prostate Cancer Treatment

Profound Medical Corp. has inked a joint development agreement with Royal Philips to help the company's proprietary TULSA (Transurethral Ultrasound Ablation) technology designed to treat patients with prostate cancer on Philips' Ingenia and Achieva 3T MRI systems. It is explained that Profound's TULSA technology is emerging as a new minimally invasive, whole gland ablation of the prostate. It has the potential for outcomes comparable to the best of current treatment options, but with lower rates of side effects and higher quality of life for patients.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INPHI:NA €0.00 EUR 0.00

INPHI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bridgestone Corp ¥4,513 JPY -31.00
Eaton Corp PLC $60.57 USD -0.58
FUJIFILM Holdings Corp ¥4,503 JPY -6.00
Linde AG €171.00 EUR +1.98
Whirlpool Corp $171.84 USD -4.26
View Industry Companies

Industry Analysis


Industry Average

Valuation INPHI Industry Range
Price/Earnings 100.0x
Price/Sales 1.0x
Price/Book 2.0x
Price/Cash Flow 62.7x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHILIPS ELECTRONICS NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at